Invesco Nasdaq Biotechnology ETF Rating $22.61 -0.04 (-0.18%) Closing price 01/31/2025 03:59 PM EasternExtended Trading$22.55 -0.06 (-0.28%) As of 01/31/2025 04:53 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ratings Stock AnalysisChartDividendHeadlinesHoldingsOptions ChainOwnershipRatingsShort InterestTrends Invesco Nasdaq Biotechnology ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.IBBQ Aggregate RatingModerate Buy 2.70Holdings in IBBQ have an aggregate rating of Moderate Buy based on 747 analyst ratings issued in the past year covering 49 companies (78.4% of the portfolio).IBBQ Aggregate Price Target$22.61High Prediction$22.61Average Prediction$22.61Low Prediction$22.61Holdings in IBBQ have an aggregate price target of $22.61 and a range of $22.61 to $22.61 covering 49 companies (78.4% of the portfolio).IBBQ Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy15 Buy rating(s)Moderate Buy27 Moderate Buy rating(s)Hold7 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Invesco Nasdaq Biotechnology ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 49 IBBQ Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings8.45%GILDGilead Sciences$97.20+0.3%4.7593 of 5 stars2.70$98.39 1.2%27Analyst ForecastShort Interest ↑Positive News8.13%AMGNAmgen$285.42+0.5%4.8816 of 5 stars2.44$314.00 10.0%27Upcoming EarningsAnalyst ForecastPositive News7.69%VRTXVertex Pharmaceuticals$461.68+5.3%3.7459 of 5 stars2.61$502.58 8.9%28Analyst DowngradeNews CoverageGap UpHigh Trading Volume7.14%REGNRegeneron Pharmaceuticals$672.98-1.5%4.707 of 5 stars2.65$1,004.57 49.3%23Upcoming EarningsAnalyst ForecastAnalyst Revision3.86%AZNAstraZeneca$70.76-0.7%3.9255 of 5 stars3.00$89.75 26.8%9Upcoming EarningsShort Interest ↑3.34%ALNYAlnylam Pharmaceuticals$271.31-2.1%4.5613 of 5 stars2.72$298.61 10.1%25Insider TradeAnalyst RevisionNews Coverage2.16%ILMNIllumina$132.74-0.2%4.3742 of 5 stars2.70$165.63 24.8%20Short Interest ↓Positive News2.02%BIIBBiogen$143.93-1.6%4.8042 of 5 stars2.43$228.80 59.0%28Analyst ForecastAnalyst Revision2.00%ARGXargenx$655.13-1.6%2.7889 of 5 stars2.86$658.39 0.5%22Positive News1.69%SMMTSummit Therapeutics$21.50-3.8%3.0853 of 5 stars2.86$33.57 56.1%7Gap Down1.61%UTHRUnited Therapeutics$351.17-0.3%4.3305 of 5 stars2.73$378.36 7.7%15Insider TradeShort Interest ↓News CoveragePositive News1.51%SNYSanofi$54.34+0.4%3.342 of 5 stars3.25$60.00 10.4%4Earnings ReportAnalyst UpgradeShort Interest ↑Analyst RevisionNews Coverage1.44%MRNAModerna$39.42-3.9%4.5506 of 5 stars2.09$67.26 70.6%23Analyst Forecast1.44%NBIXNeurocrine Biosciences$151.82-1.0%4.6262 of 5 stars2.82$166.10 9.4%22Upcoming EarningsAnalyst ForecastInsider TradeAnalyst RevisionNews Coverage1.36%INCYIncyte$74.16+0.5%4.5739 of 5 stars2.35$75.71 2.1%20Short Interest ↓1.36%INSMInsmed$76.58+0.4%2.719 of 5 stars3.00$83.67 9.3%16Insider TradeShort Interest ↑1.31%ITCIIntra-Cellular Therapies$127.08+0.1%4.3007 of 5 stars2.53$103.62 -18.5%15Analyst ForecastShort Interest ↓1.30%RPRXRoyalty Pharma$31.580.0%4.7948 of 5 stars3.00$41.67 31.9%7Positive News1.29%VTRSViatris$11.28-1.2%3.1196 of 5 stars2.00$13.67 21.2%3News CoverageHigh Trading Volume1.15%BMRNBioMarin Pharmaceutical$63.36-0.8%4.9692 of 5 stars2.74$94.20 48.7%23Short Interest ↓1.10%BNTXBioNTech$123.77+2.4%2.2353 of 5 stars2.88$142.72 15.3%17Short Interest ↑1.08%SRPTSarepta Therapeutics$113.72-0.6%4.8995 of 5 stars2.91$178.71 57.2%22Analyst ForecastAnalyst Revision1.05%PCVXVaxcyte$88.32-3.9%2.0551 of 5 stars3.00$145.71 65.0%8News Coverage1.04%MEDPMedpace$349.15-0.3%4.3079 of 5 stars2.45$381.44 9.2%11Short Interest ↓0.91%EXELExelixis$33.15+0.7%4.5445 of 5 stars2.53$36.06 8.8%19Analyst Forecast0.79%ROIVRoivant Sciences$11.13-2.1%3.0968 of 5 stars3.00$17.93 61.1%8Analyst Upgrade0.75%TEMTempus AI$57.39+0.3%1.4861 of 5 stars2.75$56.36 -1.8%12Upcoming EarningsInsider TradeGap UpHigh Trading Volume0.74%ASNDAscendis Pharma A/S$130.66+2.6%3.4336 of 5 stars2.93$191.57 46.6%14Upcoming EarningsAnalyst ForecastShort Interest ↓0.71%JAZZJazz Pharmaceuticals$124.37-0.5%4.9474 of 5 stars2.87$177.00 42.3%15Short Interest ↓Analyst RevisionPositive News0.69%MDGLMadrigal Pharmaceuticals$334.80-1.0%3.6638 of 5 stars2.69$351.67 5.0%13Short Interest ↓0.69%BPMCBlueprint Medicines$112.53-1.3%0.9434 of 5 stars2.65$123.56 9.8%20Short Interest ↑0.68%HALOHalozyme Therapeutics$56.64+0.4%4.6073 of 5 stars2.60$60.89 7.5%10Short Interest ↑Positive News0.67%RVMDRevolution Medicines$42.95-0.3%4.4555 of 5 stars3.08$66.25 54.2%120.66%BBIOBridgeBio Pharma$34.21-4.9%4.0242 of 5 stars2.92$49.00 43.2%13Insider TradeShort Interest ↑News Coverage0.57%GHGuardant Health$46.98-5.9%3.784 of 5 stars3.00$42.63 -9.3%16Analyst ForecastShort Interest ↓0.54%CYTKCytokinetics$49.46-1.0%3.9289 of 5 stars2.87$82.79 67.4%150.52%NUVLNuvalent$85.81-2.2%2.4308 of 5 stars2.86$112.36 30.9%14Insider TradePositive News0.50%IONSIonis Pharmaceuticals$31.90-4.3%4.5154 of 5 stars2.68$60.65 90.1%19Gap Down0.48%AXSMAxsome Therapeutics$106.46-2.2%4.6175 of 5 stars3.00$132.08 24.1%14Analyst ForecastShort Interest ↓Analyst RevisionNews Coverage0.47%ALKSAlkermes$31.53-1.2%3.8733 of 5 stars2.64$36.00 14.2%11Insider TradeShort Interest ↓Analyst RevisionNews Coverage0.43%KRYSKrystal Biotech$159.74+2.4%4.8048 of 5 stars3.00$206.67 29.4%8Short Interest ↓0.43%SRRKScholar Rock$40.380.0%3.1189 of 5 stars3.14$40.43 0.1%7Analyst ForecastNews Coverage0.39%VRNAVerona Pharma$57.30+0.1%2.3081 of 5 stars3.13$53.14 -7.3%8Short Interest ↑0.39%RAREUltragenyx Pharmaceutical$43.03-0.9%4.669 of 5 stars2.93$92.43 114.8%140.38%ADMAADMA Biologics$16.15+0.3%3.8436 of 5 stars3.25$21.25 31.6%4Short Interest ↑0.37%APLSApellis Pharmaceuticals$29.01-4.5%4.7064 of 5 stars2.63$46.71 61.0%19Analyst ForecastShort Interest ↓0.37%CRSPCRISPR Therapeutics$41.59-1.1%2.6612 of 5 stars2.47$78.38 88.4%19Short Interest ↑0.35%CRNXCrinetics Pharmaceuticals$40.30+0.1%3.7562 of 5 stars3.00$72.64 80.2%11Short Interest ↑0.35%RNAAvidity Biosciences$32.93+0.9%1.3689 of 5 stars3.00$65.80 99.8%10 This page (NASDAQ:IBBQ) was last updated on 2/1/2025 by MarketBeat.com Staff From Our PartnersElon’s #1 AI Stock” SET TO SOARForget ChatGPT! Because Elon Musk's AI promises to be 100x more powerful.Behind the Markets | SponsoredWill DeepSeek pop the AI bubble?An overseas AI rival sent shockwaves through the U.S. tech market last week... Leaving millions of investor...Chaikin Analytics | SponsoredBetter than Bitcoin – and potentially more profitableThe world is obsessed with Bitcoin again... And for a good reason: It just soared beyond $100,000. Bitcoin ...Brownstone Research | SponsoredDid You See Trump’s Manhattan Project Bombshell?This secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | SponsoredTrump vs. TexasEver since Donald Trump won the election, U.S. states have been rushing to pass new currency rules. These r...Stansberry Research | SponsoredTurning Panic Into OpportunityAI stocks were hammered on Jan. 27. That includes Nvidia, the undisputed leader in the artificial intellige...Weiss Ratings | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredWill Elon trigger another AI flash crash?AI continues to dominate financial headlines in 2025...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Invesco Nasdaq Biotechnology ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Invesco Nasdaq Biotechnology ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
